We are delighted to add a summary of a recent speaker event titled: Rituximab in Rheumatology - Lessons Learnt, featuring Associate Professor Alberta Hoi, a rheumatologist from Austin Health.
The publication summarises a symposium from the 2022 ARA Annual Conference on rituximab use, following the positive recommendation from PBAC that all brands of rituximab be changed to ‘Unrestricted benefits’.
Please login below to download this issue (PDF)